Video Capture and Synchronisation System - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Video Capture and Synchronisation System

Pharmaceutical Technology
Volume 37, Issue 10, pp. 18
Untitled Document

A video system provides texture analysis data and analysis capabilities for pharmaceutical and supplement manufacturers. The Video Capture and Synchronisation System can record tests and replay them frame by frame simultaneously with their corresponding force-distance-time graphs. The system includes a moveable video camera, a transparent test platform, and an optional light attachment. To conduct a test, the camera is positioned in the most appropriate location for testing. As the TA.XT plus texture analyser begins collecting data, a signal is relayed to the Video Capture Interface, which initiates recording at up to 50 frames per second. Data is collected and analyzed by Exponent Stable Micro Systems’ proprietary software.

Stable Micro Systems

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here